Floatz logo

(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE

Paravertebral Block

Tanta UniversitySmall moleculePhase 4 / ApprovedActive
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
89/ 100

Competitive context

7 Active assets in the Paravertebral Block cohort.

Asset / SponsorPhaseRating
LIDOCAINE
Tanta University
Phase 4BB
L-Bupivacaine
University of Rijeka
Phase 4BB
SUFENTANIL CITRATE
University of Rijeka
N/AD
Desflurane
University of Rijeka
N/AD
PROPOFOL
University of Rijeka
N/AD
CISATRACURIUM ION
University of Rijeka
N/AD
RAMIFENTANYL
University of Rijeka
N/AD

Same molecule, other indications

(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE is also rated in:

major depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →
major depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →